HedgePath Pharmaceuticals Inc

Find more results for Watson Laboratories, Inc

Officers and directors

Frank E. O'Donnell Jr.
Executive Chairman of the Board
Nicholas J. Virca
President, Chief Executive Officer
Garrison J. Hasara CPA
Chief Financial Officer, Treasurer
Stefan J. Cross
R. Dana Ono Ph.D.
Independent Director
Samuel P. Sears Jr.
Independent Director
W. Mark Watson CPA
Independent Director


324 S Hyde Park Ave Ste 350
TAMPA, FL 33606-4110
United States - Map
+1-813-8642559 (Phone)
+1-813-5270500 (Fax)

Website links

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics for patients with certain cancers. The Company focuses on the development of therapies for skin, lung and prostate cancers in the United States market. The Company's is engaged to develop and to commercialize SUBA-Itraconazole Capsules for the treatment of human cancer via oral administration. The Company's SUBA technology (which stands for super bioavailability) is designed to improve the bioavailability of orally administered drugs that are soluble.

Related companies

* Delayed by up to 20 minutes -  Disclaimer